Preventive and curative effects of dicaffeoylquinic acid on early pulmonary fibrosis in mice
- 1. Academy of Military Medical Sciences, Beijing (China). Inst. of Radiation Medicine
Description
Objective: To explore the effect of dicaffeoylquinic acid (IBE5) on prevention and treatment of pulmonary fibrosis induced by bleomycin (BLM) in mice and its mechanism. Methods: Hydroxyproline content determination, imaging analysis, collagen I and III assay, α-smooth muscle actin (α-SMA) and matrix metalloproteinase 7 (MMP-7 ) immunohistochemistry were performed. Results: 1)Hydroxyproline content decreased in fibrotic lung tissue after administration of IBE5(P<0.05). 2)The number of pulmonary alveoli reduced, alveolus interstitium was thickened and collagen deposition and fibrosis were formed in lung tissue of BLM group. The break of pulmonary alveoli and extension of pulmonary fibrosis were decreased by use of IBE5 (P<0.05). 3)A lot of collagen I and III were synthesized in lung interstitium in BLM group and their quantity was reduced in IBE5 group (P<0.05). 4) In BLM group, α-SMA expression increased and located in myofibroblasts in fibrotic area, and MMP7 immunohistochemical signal was located in myofibroblasts also. They were decreased in IBE5 group(P<0.05). Conclusion: IBE5 plays a preventive and curative role in pulmonary fibrosis by inhibition of transformation of fibroblasts towards myofibroblasts and MMP7 expression. (authors)
Additional details
Publishing Information
- Journal Title
- Chinese Journal of Radiological Medicine and Protection
- Journal Volume
- 25
- Journal Issue
- 1
- Journal Page Range
- p. 36-38
- ISSN
- 0254-5098
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 39002307
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
- Descriptors DEI
- BLEOMYCIN; COLLAGEN; DRUGS; FIBROSIS; LUNGS; MEDICAL EXAMINATIONS; PROTEINS; QUININE; RADIATION INJURIES; RESPIRATORY SYSTEM DISEASES; THERAPY
- Descriptors DEC
- ALKALOIDS; ANTI-INFECTIVE AGENTS; ANTIBIOTICS; ANTIMICROBIAL AGENTS; ANTIMITOTIC DRUGS; ANTINEOPLASTIC DRUGS; ANTIPYRETICS; BIOLOGICAL EFFECTS; BIOLOGICAL RADIATION EFFECTS; BODY; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DISEASES; DRUGS; INJURIES; MEDICAL SURVEILLANCE; MEDICINE; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; PROTEINS; RADIATION EFFECTS; RESPIRATORY SYSTEM; SCLEROPROTEINS
Optional Information
- Notes
- 6 figs., 6 refs.